EGFR and head and neck cancer: The simultaneous targeting of ITGB1 and EGFR also produced radio-sensitizing effects on head and neck cancer, aIIB2 increased cytotoxicity and radio-sensitization in a variety of head and neck cancer cells when combined with cetuximab and X-rays [118, 146].